Bio Plus Co

Bio Plus Co Accounts Payable

The Accounts Payable of Bio Plus Co (099430.KQ) as of Nov 20, 2026 is 619.06 M KRW. In the previous year, Accounts Payable was 1.01 B KRW — a change of -38.71% (lower).

Accounts Payable

619.06 MKRW

YoY

-38.71%

Last updated:

Accounts Payable of Bio Plus Co is 2025 619.06 M KRW. Accounts Payable of Bio Plus Co was 2024 1.01 B KRW. It decreases by -38.71% lower compared to the previous year.

The Bio Plus Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2020
774.75 M KRW
Jan 1, 2021
994.24 M KRW
Jan 1, 2022
1.15 B KRW
Jan 1, 2023
606.23 M KRW
Jan 1, 2024
1.01 B KRW
Jan 1, 2025
619.06 M KRW
The Bio Plus Co Accounts Payable history
YEARAccounts PayableYoY
619.06 MKRW-38.71%
1.01 BKRW+66.61%
606.23 MKRW-47.38%
1.15 BKRW+15.88%
994.24 MKRW+28.33%
774.75 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Plus Co Stock analysis

What does Bio Plus Co do? BioPlus Co., Ltd. generates revenue through the manufacturing and sale of dermal fillers, primarily hyaluronic acid fillers for temporary facial wrinkle improvement. The company also produces and sells anti-adhesion agents to prevent surgical adhesions, biomaterials for joint tissue repair, and other tissue restoration products. These products are supplied to medical professionals and healthcare facilities requiring cosmetic and surgical solutions. The firm targets the medical and cosmetic sectors, focusing on tissue restoration applications for both aesthetic and functional needs. The company's product portfolio includes biomaterials for tissue restoration, specifically designed for temporary facial wrinkle correction, anti-adhesion solutions for surgical sites, and joint tissue repair materials. These offerings cater to healthcare providers seeking advanced biomaterials for patient care. BioPlus Co., Ltd. serves the medical industry by providing specialized products that address both cosmetic enhancement and post-surgical recovery requirements. BioPlus Co., Ltd. operates within the biomaterials sector, focusing on dermal fillers and tissue repair solutions. Its products are utilized by medical practitioners for facial aesthetics and surgical applications. The company's revenue streams are derived from direct sales of these biomaterial products to healthcare institutions and professionals in the medical field. Bio Plus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Plus Co stock

Accounts Payable of Bio Plus Co is 619.06 M KRW in 2025.

Accounts Payable of Bio Plus Co changed from 1.01 B KRW to 619.06 M KRW, representing a -38.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Bio Plus Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Bio Plus Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bio Plus Co

All Key Metrics — Bio Plus Co